Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yawei Zhang

Showing results (721-730 of 748) with videos related to

Pageof 75
Sort By:
American Journal of Epidemiology|January 6, 2010
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph ConsortiumChristine F Skibola, Paige M Bracci, Alexandra Nieters, et al.
Blood|October 11, 2012
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortiumAlexandra Nieters, Lucia Conde, Susan L Slager, et al.
Journal of Orthopaedic Translation|November 16, 2022
Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III studyJiemei Gu, Hao Zhang, Qingyun Xue, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRSSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
BMC Medicine|October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trialMingtong Xu, Kan Sun, Wenjie Xu, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Joshua N Sampson, James R Cerhan, et al.
American Journal of Epidemiology|February 26, 2015
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
The Lancet Regional Health. Southeast Asia|May 17, 2024
Mapping recommendations towards an Asian Code Against Cancer (ACAC) as part of the World Code Against Cancer Framework: an Asian National Cancer Centers Alliance (ANCCA) initiativeSok King Ong, Sarah K Abe, Gillian Li Gek Phua, et al.
Diabetologia|November 21, 2025
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trialDalong Zhu, Jianhua Ma, Weimin Wang, et al.
Plos Genetics|May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaKarin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
Pageof 75

Showing results (721-730 of 748) with videos related to

Sort By:
Pageof 75
American Journal of Epidemiology|January 6, 2010
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph ConsortiumChristine F Skibola, Paige M Bracci, Alexandra Nieters, et al.
Blood|October 11, 2012
PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortiumAlexandra Nieters, Lucia Conde, Susan L Slager, et al.
Journal of Orthopaedic Translation|November 16, 2022
Denosumab biosimilar (LY06006) in Chinese postmenopausal osteoporotic women: A randomized, double-blind, placebo-controlled, multicenter phase III studyJiemei Gu, Hao Zhang, Qingyun Xue, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 4, 2022
B-Cell NHL Subtype Risk Associated with Autoimmune Conditions and PRSSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
BMC Medicine|October 9, 2023
Fotagliptin monotherapy with alogliptin as an active comparator in patients with uncontrolled type 2 diabetes mellitus: a randomized, multicenter, double-blind, placebo-controlled, phase 3 trialMingtong Xu, Kan Sun, Wenjie Xu, et al.
Journal of the National Cancer Institute. Monographs|September 1, 2014
Rationale and Design of the International Lymphoma Epidemiology Consortium (InterLymph) Non-Hodgkin Lymphoma Subtypes ProjectLindsay M Morton, Joshua N Sampson, James R Cerhan, et al.
American Journal of Epidemiology|February 26, 2015
Associations of non-Hodgkin Lymphoma (NHL) risk with autoimmune conditions according to putative NHL lociSophia S Wang, Claire M Vajdic, Martha S Linet, et al.
The Lancet Regional Health. Southeast Asia|May 17, 2024
Mapping recommendations towards an Asian Code Against Cancer (ACAC) as part of the World Code Against Cancer Framework: an Asian National Cancer Centers Alliance (ANCCA) initiativeSok King Ong, Sarah K Abe, Gillian Li Gek Phua, et al.
Diabetologia|November 21, 2025
Efficacy and safety of efsubaglutide alfa in individuals with type 2 diabetes (SUPER1): a randomised, double-blind, placebo-controlled, Phase IIb/III trialDalong Zhu, Jianhua Ma, Weimin Wang, et al.
Plos Genetics|May 3, 2011
GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphomaKarin E Smedby, Jia Nee Foo, Christine F Skibola, et al.
Pageof 75